These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3923882)

  • 21. Infectious complications of lung transplantation. Impact of cystic fibrosis.
    Flume PA; Egan TM; Paradowski LJ; Detterbeck FC; Thompson JT; Yankaskas JR
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1601-7. PubMed ID: 7516251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differences in eucaryotic cell binding of Pseudomonas.
    Cervin MA; Simpson DA; Smith AL; Lory S
    Microb Pathog; 1994 Nov; 17(5):291-9. PubMed ID: 7536882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of pan-resistant bacterial pathogens on survival after lung transplantation in cystic fibrosis: results from a single large referral centre.
    Dobbin C; Maley M; Harkness J; Benn R; Malouf M; Glanville A; Bye P
    J Hosp Infect; 2004 Apr; 56(4):277-82. PubMed ID: 15066737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of Pseudomonas cepacia in cystic fibrosis patient.
    Marques Ede A; Pinto RM; Dallallana LT; de Oliveira EF; Suassuna I
    Mem Inst Oswaldo Cruz; 1993; 88(1):125-9. PubMed ID: 7504157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal serum IgG response to Pseudomonas cepacia surface antigens in cystic fibrosis.
    Aronoff SC; Quinn FJ; Stern RC
    Pediatr Pulmonol; 1991; 11(4):289-93. PubMed ID: 1722035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.
    Jacques I; Derelle J; Weber M; Vidailhet M
    Eur J Pediatr; 1998 May; 157(5):427-31. PubMed ID: 9625343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of pyrolysis mass spectroscopy and SDS-PAGE in the study of the epidemiology of Pseudomonas cepacia in cystic fibrosis.
    Corkill JE; Sisson PR; Smyth A; Deveney J; Freeman R; Shears P; Heaf D; Hart CA
    J Med Microbiol; 1994 Aug; 41(2):106-11. PubMed ID: 7519269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology.
    Goldmann DA; Klinger JD
    J Pediatr; 1986 May; 108(5 Pt 2):806-12. PubMed ID: 3517271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas cepacia in the sputum of cystic fibrosis patients.
    Taylor PC; Kalamatianos CC
    Pathology; 1994 Jul; 26(3):315-7. PubMed ID: 7527513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients.
    Lewin LO; Byard PJ; Davis PB
    J Clin Epidemiol; 1990; 43(2):125-31. PubMed ID: 2303842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies of Pseudomonas aeruginosa to colonize and to persist in the cystic fibrosis lung.
    Kubesch P; Lingner M; Grothues D; Wehsling M; Tümmler B
    Scand J Gastroenterol Suppl; 1988; 143():77-80. PubMed ID: 3133755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Microbiological parameters of clinical interest in pulmonary infection in cystic fibrosis].
    Ballestero S; Escobar H; Suárez L; Baquero F
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):245-9. PubMed ID: 9044640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications.
    Burdge DR; Noble MA; Campbell ME; Krell VL; Speert DP
    Clin Infect Dis; 1995 Feb; 20(2):445-8. PubMed ID: 7537977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inapparent transmission of Pseudomonas (Burkholderia) cepacia among patients with cystic fibrosis.
    Lipuma JJ; Marks-Austin KA; Holsclaw DS; Winnie GB; Gilligan PH; Stull TL
    Pediatr Infect Dis J; 1994 Aug; 13(8):716-9. PubMed ID: 7526328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis.
    Snell GI; de Hoyos A; Krajden M; Winton T; Maurer JR
    Chest; 1993 Feb; 103(2):466-71. PubMed ID: 7679347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible nosocomial transmission of Pseudomonas cepacia in patients with cystic fibrosis.
    Pegues DA; Schidlow DV; Tablan OC; Carson LA; Clark NC; Jarvis WR
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):805-12. PubMed ID: 7519103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Iron deficiency and Pseudomonas aeruginosa colonization in cystic fibrosis].
    de Montalembert M; Fauchère JL; Bourdon R; Lenoir G; Rey J
    Arch Fr Pediatr; 1989 May; 46(5):331-4. PubMed ID: 2504126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.